Press "Enter" to skip to content

Pharmaceutical companies with the most orphan drugs

0
Copyright © DrugPatentWatch. Originally published at Pharmaceutical companies with the most orphan drugs

Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans.

The protection granted to orphan drugs is quite strong. The FDA is barred from approving any other biologic or small-molecule drug, generic/follow-on or otherwise, treating the same orphan disease for seven years.

This chart shows the companies which have received the most orphan drug exclusivities in the past five years.

The companies with the most orphan drug approvals are:

    For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

    Make Better Decisions with DrugPatentWatch

    » Start Your Free Trial Today «

    Copyright © DrugPatentWatch. Originally published at Pharmaceutical companies with the most orphan drugs
      Find your next blockbuster

      Get accurate and timely intelligence — in just a few clicks

      ✓ Free trial

      ✓ No credit card

       

      DrugPatentWatch - Make Better Decisions